By overlapping the DARs and DEGs, the activation marker CD69 was highly expressed in DN2B57, and the antigen-presenting and activation marker CD83 was highly expressed in MB and NB, suggesting a highly activated state of B cells in BD patients58 (Supplementary Fig. 9e, f). This evidence concerns the gene CD83 and Behcet disease.